On December 7, 2022, the board of directors of Hoth Therapeutics, Inc. increased the size of the Board to five members and appointed Jeff Pavell, D.O., as a member of the Board to fill the vacancy created by the increase in the size of the Board. In addition, effective as of December 7, 2022, David Sarnoff resigned as a member of the compensation committee of the Board and Dr. Pavell was appointed as a member of the Compensation Committee to fill the vacancy created by Mr. Sarnoff's resignation. Since January 2017, Dr. Pavell, age 55, has served as Chief of Rehabilitation Medicine at Englewood Health, and since November 2021, he has been on the teaching staff at New York-Presbyterian.

In addition, since December 2020 he has been on the teaching staff at Hackensack Meridian School of Medicine at Seton Hall. Furthermore, since 2010, Dr. Pavell has served as a partner at Patient Care Associates, an outpatient surgical center, and since 2002, he has served as a Partner at the Physical Medicine and Rehabilitation Center, a private medical practice serving patients with spine, sports and occupational injuries. Dr. Pavell is a Board Certified physician specializing in the field of physical medicine and rehabilitation.

Dr. Pavell is also certified in pain medicine and specializes in the most advanced non-operative treatments for spine, sports and interventional pain medicines. Dr. Pavell received his bachelor of arts from Johns Hopkins University and his D.O. degree with honors from the New York College of Osteopathic Medicine. Since January 2021, Dr. Pavell has served as a member of the board of directors of FoxWayne Enterprises Acquisition Corp.

as well as chairman of the audit committee of FoxWayne and a member of the compensation committee of FoxWayne. Furthermore, since September 2022, Dr. Pavell has served as a director of Silo Pharma, Inc. as well as a member of the audit committee, compensation committee and chair of the nominating and corporate governance committee of Silo. The Company believes that Dr. Pavell is qualified to serve as a director of the Company due to his extensive experience practicing in the healthcare industry as well as his prior experience serving as a director for other public companies.